We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sterile Drug Compounder Rapped on Procedures
The FDA issued a Form 483 to an Arizona drug compounder for lax monitoring of areas where sterile drugs are produced and for not establishing procedures to prevent contamination of products.